Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions

NCT01435031 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01435031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01435031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2011
Completion date
December 31, 2017
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic total occlusion (cto), coronary artery disease (cad)